Baird Starts Optimer Pharmaceuticals (OPTR) at Outperform, $16 PT
Tweet Send to a Friend
Baird initiates coverage on Optimer Pharmaceuticals (NASDAQ: OPTR) with a Outperform. PT $16.00.
"We expect Dificid sales volume to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"We expect Dificid sales volume to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
